Evidence map›Paper›PMID 41846949›Full record

ArticlebioRxiv : the preprint server for biology2026

Phage protease enzymes activate CBASS antiphage immunity.

Samuel J Hobbs, Philip J Kranzusch

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Samuel J HobbsDepartment of Microbiology, Harvard Medical School, Boston, MA 02115, USA.
Philip J KranzuschDepartment of Microbiology, Harvard Medical School, Boston, MA 02115, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyclic oligonucleotide-based antiphage signaling systems (CBASS) are immunity pathways in bacteria that use a cGAS/DncV-like nucleotidyltransferase (CD-NTase) enzyme to sense phage infection and initiate antiviral defense. Bacteria encode thousands of diverse CBASS operons, demonstrating a critical role for CD-NTase activation in controlling the prokaryotic response to viral infection. Here we discover proteolytic cleavage by phage prohead proteases as a mechanism of CD-NTase activation and demonstrate that diverse CBASS operons function as molecular sensors of protease activity. We reconstitute CBASS recognition of phage T4 infection

Identifiers

PMID41846949
PMCPMC12991175

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.